Bank Of New York Mellon Corp Sangamo Therapeutics, Inc Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $1.38 Million - $2.53 Million	498,134 New	498,134 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $220,267 - $329,628	51,585 Added 11.17%	513,493 $2.52 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $61,395 - $116,238	18,718 Added 4.22%	461,908 $1.91 Million
Q1 2022 May 11, 2022	BUY	$5.23 - $7.82 $21,103 - $31,553	4,035 Added 0.92%	443,190 $2.58 Million
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $22,292 - $33,546	3,058 Added 0.7%	439,155 $3.29 Million

Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $281,778 - $375,600	31,274 Added 7.73%	436,097 $3.93 Million
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $865,090 - $1.08 Million	-85,063 Reduced 17.36%	404,823 $4.85 Million
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $202,542 - $317,402	-18,616 Reduced 3.66%	489,886 $6.14 Million
Q4 2020 Feb 09, 2021	SELL	$9.23 - $18.18 $188,744 - $371,762	-20,449 Reduced 3.87%	508,502 $7.94 Million
Q3 2020 Nov 12, 2020	SELL	$9.38 - $12.48 $136,328 - $181,384	-14,534 Reduced 2.67%	528,951 $5 Million
Q2 2020 Aug 12, 2020	BUY	$6.21 - $11.83 $179,096 - $341,177	28,840 Added 5.6%	543,485 $4.87 Million
Q1 2020 May 06, 2020	BUY	$5.05 - $8.85 $29,582 - $51,843	5,858 Added 1.15%	514,645 $3.28 Million
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $24,844 - $36,199	-3,094 Reduced 0.6%	508,787 $4.26 Million
Q3 2019 Nov 07, 2019	BUY	$9.05 - $12.22 $59,956 - $80,957	6,625 Added 1.31%	511,881 $4.63 Million
Q2 2019 Aug 12, 2019	BUY	$8.75 - $13.03 $313,328 - $466,591	35,809 Added 7.63%	505,256 $5.44 Million
Q1 2019 May 14, 2019	BUY	$7.72 - $12.81 $44,791 - $74,323	5,802 Added 1.25%	469,447 $4.48 Million
Q4 2018 Feb 11, 2019	BUY	$9.51 - $16.6 $84,734 - $147,906	8,910 Added 1.96%	463,645 $5.32 Million
Q3 2018 Nov 09, 2018	BUY	$13.05 - $19.05 $97,509 - $142,341	7,472 Added 1.67%	454,735 $0
Q2 2018 Aug 06, 2018	SELL	$13.9 - $19.8 $230,531 - $328,383	-16,585 Reduced 3.58%	447,263 $6.35 Million
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $1.19 Million - $1.87 Million	71,135 Added 18.11%	463,848 $8.81 Million
Q4 2017 Feb 09, 2018	BUY	$11.6 - $17.35 $4.56 Million - $6.81 Million	392,713	392,713 $6.44 Million

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

Wasatch Advisors Inc Salt Lake City, UT

20.1M
Shares

$6.44 Million
0.07% of portfolio
Armistice Capital, LLC New York, NY

17M
Shares

$5.43 Million
0.15% of portfolio
Black Rock Inc. New York, NY

13.3M
Shares

$4.25 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

12.2M
Shares

$3.9 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.94M
Shares

$1.58 Million
0.01% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $50.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account